Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Cellegy discovers compounds that modulate topical inflammatory and allergic responses

June 16, 1997

Favorable preclinical results with REPEL-CV for cardiovascular surgery

June 13, 1997

Merck & Co. continues to develop 5alpha-reductase inhibitors

June 11, 1997

Inhibitors of 5alpha-reductase prepared by Merck & Co.

June 10, 1997

Preparation and use of 5alpha-reductase type 1 inhibitors described by Merck & Co.

June 6, 1997

Penederm receives SBIR grant for research on vitamin D derivative

June 5, 1997

Bristol-Myers Squibb selects diacid for development as antipsoriatic

June 4, 1997

ProCyte launches GraftCyte products

May 28, 1997

Dusa reports progress in phase III trial of Levulan PDT

May 23, 1997

VIMRx acquires worldwide rights to wound-healing agent

May 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...